KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CRISPR Therapeutics AG (CRSP) Current Assets (2016 - 2025)

Historic Current Assets for CRISPR Therapeutics AG (CRSP) over the last 11 years, with Q4 2025 value amounting to $2.0 billion.

  • CRISPR Therapeutics AG's Current Assets rose 250.57% to $2.0 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $2.0 billion, marking a year-over-year increase of 250.57%. This contributed to the annual value of $2.0 billion for FY2025, which is 250.57% up from last year.
  • According to the latest figures from Q4 2025, CRISPR Therapeutics AG's Current Assets is $2.0 billion, which was up 250.57% from $1.9 billion recorded in Q3 2025.
  • In the past 5 years, CRISPR Therapeutics AG's Current Assets registered a high of $2.6 billion during Q2 2021, and its lowest value of $1.7 billion during Q2 2025.
  • Over the past 5 years, CRISPR Therapeutics AG's median Current Assets value was $1.9 billion (recorded in 2022), while the average stood at $2.0 billion.
  • As far as peak fluctuations go, CRISPR Therapeutics AG's Current Assets skyrocketed by 17142.65% in 2021, and later crashed by 2334.99% in 2022.
  • Quarter analysis of 5 years shows CRISPR Therapeutics AG's Current Assets stood at $2.4 billion in 2021, then dropped by 23.35% to $1.9 billion in 2022, then increased by 2.97% to $1.9 billion in 2023, then grew by 1.52% to $1.9 billion in 2024, then grew by 2.51% to $2.0 billion in 2025.
  • Its Current Assets was $2.0 billion in Q4 2025, compared to $1.9 billion in Q3 2025 and $1.7 billion in Q2 2025.